What does APOGREZ do?

APOGREZ is a pharmacy in Grez-Doiceau. Public Limited, started on 17 November 1988, 1 establishment.

What is the address of APOGREZ?

The registered office of APOGREZ is located at Chaussée de Jodoigne 20, 1390 Grez-Doiceau.

Is APOGREZ still active?

Yes. According to the CBE (30 October 2026) APOGREZ is active, legal situation “Normale toestand”, started on 17 November 1988.

Is APOGREZ registered on Peppol?

Yes, APOGREZ is registered on the Peppol network with ID 0208:0435727364.

What is the enterprise number of APOGREZ?

The enterprise number of APOGREZ is BE0435727364.

When was APOGREZ founded?

APOGREZ was founded on 17 November 1988.

Who are the directors of APOGREZ?

According to the 2025 annual accounts, the directors of APOGREZ are: GGR GUERDER GENTELET ROBIN SRL, NATHALIE MAHIEU, PAUL RANSART.

Is APOGREZ a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 17 November 1988; 5 annual accounts filed, latest fiscal year 2025; 3 directors known from the annual account.

How much profit did APOGREZ make in 2025?

APOGREZ posted a profit after taxes of € 8,830 in financial year 2025.

What is the revenue of APOGREZ?

As a small company, APOGREZ is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 36,615.

APOGREZ (Public Limited) - Grez-Doiceau - BE0435727364

Dossier APOGREZ, printed on 30 October 2026 from databakkes.be/en/0435727364/apogrez. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

APOGREZ from Grez-Doiceau, company number BE0435727364, closed financial year 2025 with a result of € 8,830 after tax. For that financial year APOGREZ recorded a gross margin of € 36,615 and equity of € 520,779. Compared with financial year 2024, the result moved from € 13,727 to € 8,830. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 22, 2026.

What it is worth Healthy

€ 520,779

▼ 32% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 8,830

▼ 36% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 7,944

▲ 6% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 250,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 113,916

▼ 12% vs 2024

Of which on lease € 113,916.

Debts at end 2025

Bank debt ≈ 17 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 419,836

▼ 5% vs 2024

€ 24,218 is repaid this year. At this pace the long-term loan is gone in ≈ 17 years.

Owed to suppliers

€ 1,842

▲ 73% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 12,599

▼ 60% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 66,545 Gross margin 2022: € 66,545 First fiscal year in the series	€ 28,313 Gross margin 2023: € 28,313 ▼ 57% vs 2022 (€ 66,545) Unfavourable step	€ 31,857 Gross margin 2024: € 31,857 ▲ 13% vs 2023 (€ 28,313) Favourable step	€ 36,615 Gross margin 2025: € 36,615 ▲ 15% vs 2024 (€ 31,857) Favourable step	▲ 15%
Profit after taxes	€ 35,218 Profit after taxes 2022: € 35,218 First fiscal year in the series	€ -6,414 Profit after taxes 2023: € -6,414 ▼ € 41,632 vs 2022 (€ 35,218) Unfavourable step	€ 13,727 Profit after taxes 2024: € 13,727 ▲ € 20,142 vs 2023 (€ -6,414) Favourable step	€ 8,830 Profit after taxes 2025: € 8,830 ▼ 36% vs 2024 (€ 13,727) Unfavourable step	▼ 36%
Equity	€ 754,635 Equity 2022: € 754,635 First fiscal year in the series	€ 748,221 Equity 2023: € 748,221 ▼ 1% vs 2022 (€ 754,635) Unfavourable step	€ 761,949 Equity 2024: € 761,949 ▲ 2% vs 2023 (€ 748,221) Favourable step	€ 520,779 Equity 2025: € 520,779 ▼ 32% vs 2024 (€ 761,949) Unfavourable step	▼ 32%
Total debts	€ 534,937 Total debts 2022: € 534,937 First fiscal year in the series	€ 543,687 Total debts 2023: € 543,687 ▲ 2% vs 2022 (€ 534,937) Unfavourable step	€ 484,646 Total debts 2024: € 484,646 ▼ 11% vs 2023 (€ 543,687) Favourable step	€ 697,831 Total debts 2025: € 697,831 ▲ 44% vs 2024 (€ 484,646) Unfavourable step	▲ 44%
Cash	€ 12,051 Cash 2022: € 12,051 First fiscal year in the series	€ 13,904 Cash 2023: € 13,904 ▲ 15% vs 2022 (€ 12,051) Favourable step	€ 7,505 Cash 2024: € 7,505 ▼ 46% vs 2023 (€ 13,904) Unfavourable step	€ 7,944 Cash 2025: € 7,944 ▲ 6% vs 2024 (€ 7,505) Favourable step	▲ 6%
Land & buildings	€ 542,442 Land & buildings 2022: € 542,442 First fiscal year in the series	€ 525,546 Land & buildings 2023: € 525,546 ▼ 3% vs 2022 (€ 542,442) Unchanged	€ 508,650 Land & buildings 2024: € 508,650 ▼ 3% vs 2023 (€ 525,546) Unchanged	€ 491,754 Land & buildings 2025: € 491,754 ▼ 3% vs 2024 (€ 508,650) Unchanged	▼ 3%
Retained profit	€ 692,635 Retained profit 2022: € 692,635 First fiscal year in the series	€ 686,221 Retained profit 2023: € 686,221 ▼ 1% vs 2022 (€ 692,635) Unfavourable step	€ 699,949 Retained profit 2024: € 699,949 ▲ 2% vs 2023 (€ 686,221) Favourable step	€ 458,779 Retained profit 2025: € 458,779 ▼ 34% vs 2024 (€ 699,949) Unfavourable step	▼ 34%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 250,000 Dividend 2025: € 250,000 Unchanged (€ 0) Unchanged
Bank debt	€ 484,411 Bank debt 2022: € 484,411 First fiscal year in the series	€ 463,285 Bank debt 2023: € 463,285 ▼ 4% vs 2022 (€ 484,411) Favourable step	€ 441,762 Bank debt 2024: € 441,762 ▼ 5% vs 2023 (€ 463,285) Favourable step	€ 419,836 Bank debt 2025: € 419,836 ▼ 5% vs 2024 (€ 441,762) Favourable step	▼ 5%
Balance sheet total	€ 1,461,624 Balance sheet total 2022: € 1,461,624 First fiscal year in the series	€ 1,458,183 Balance sheet total 2023: € 1,458,183 Unchanged (€ 1,461,624) Unchanged	€ 1,404,453 Balance sheet total 2024: € 1,404,453 ▼ 4% vs 2023 (€ 1,458,183) Unchanged	€ 1,367,874 Balance sheet total 2025: € 1,367,874 ▼ 3% vs 2024 (€ 1,404,453) Unchanged	▼ 3%

Key figures of APOGREZ, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to APOGREZ?

What happened at APOGREZ in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2027 GGR GUERDER GENTELET ROBIN SRL stepped down as director. NBB
2027 NATHALIE MAHIEU stepped down as director. NBB
2027 PAUL RANSART stepped down as director. NBB
Aug 22, 2026 New annual accounts for financial year 2025: profit of € 8,830 (▼ 36% vs 2024). filed late Source: NBB ↗
2021 GGR GUERDER GENTELET ROBIN SRL became a director. NBB
2021 NATHALIE MAHIEU became a director. NBB
2021 PAUL RANSART became a director. NBB
Jun 7, 1989 New establishment in Grez-Doiceau. KBO

In short

From € 35,218 profit in 2022 to € 8,830 profit in 2025.

Paid € 58,063 in corporate taxes since 2022.

Best year ever: 2022, with € 35,218 profit.

Paid out € 250,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

APOPHAR 100%

ALBANIMMO 30%

The stake of APOPHAR, ALBANIMMO comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

APOGREZ

The shares are held by APOPHAR (100%) and ALBANIMMO (30%).

Directors

According to the 2025 annual accounts

GGR GUERDER GENTELET ROBIN SRL

Managing director · represented by ROBIN ANTHONY

Also active at: ALBANIMMO, APOPHAR

since 2021 · until 2027

NATHALIE MAHIEU

Director

Also active at: PHARMACIE de BARRY, IMMOLENANS, NATEXIS, SWAKOPMUND

since 2021 · until 2027

PAUL RANSART

Director

Also active at: COMPAGNIE FINANCIERE ET IMMOBILIERE DE LA DYLE, PHARMACIE de BARRY, PALATINE, LENANS, IMMOLENANS, ANCIAUX, LES PHARMACIES RURALES, DIGITALE +15 more

since 2021 · until 2027

Shareholders

APOPHAR

100%

ALBANIMMO

30%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Chaussée de Jodoigne 20

1390 Grez-Doiceau

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0435.727.364

VAT number

BE 0435.727.364

Registered office

Chaussée de Jodoigne 20, 1390 Grez-Doiceau

Names & denominations

APOGREZ

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

17 November 1988

Peppol

Active · Active since 23 May 2025

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

APOGREZ

Financials

What happened to APOGREZ?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Details

Frequently asked questions